Holmes C H, Simpson K L, Okada H, Okada N, Wainwright S D, Purcell D F, Houlihan J M
University of Bristol, Department of Obstetrics and Gynaecology, St. Michael's Hospital, Great Britain.
Eur J Immunol. 1992 Jun;22(6):1579-85. doi: 10.1002/eji.1830220635.
The complement (C) regulatory proteins decay-accelerating factor (DAF, CD55) and membrane cofactor protein (MCP, CD46), which control C3 convertases, together with CD59, an inhibitor of the membrane attack complex (MAC), were found to be present in the developing human placenta from at least 6 weeks of gestation until term. Immunostaining revealed differences in the distribution of these proteins on the fetally derived trophoblast epithelium, especially in early placentae which contain trophoblast populations of diverse proliferative potential and differentiation status. Expression of all three proteins occurred on the terminally differentiated syncytiotrophoblast epithelium covering chorionic villi and which is in direct contact with maternal blood. CD59 was also expressed on the underlying villous cytotrophoblast cells and on their extra-villous derivatives. These two populations showed differential expression of the C3 convertase regulators. Villous cytotrophoblast cells expressed MCP but were largely devoid of DAF. Proliferation of this population to generate extra-villous cytotrophoblast cell columns was associated with both an increase in DAF expression and a decrease in MCP expression. Throughout placental development, expression of DAF appeared to be lower than that of MCP and CD59 as assessed by solid-phase binding assays on isolated trophoblast membranes. Early placentae were also found to contain both DAF+ and DAF- chorionic villi. Conversely, expression of CD59 appeared comparatively high and transcripts for CD59 were found to be much more abundant than those for DAF in purified trophoblast cells. C regulatory proteins appear to play an important role throughout gestation in protecting the fetally derived human conceptus from maternal C. The differential expression patterns of the proteins on trophoblast may reflect differences in requirement for specific functional activities at different locations within the placenta.
补体(C)调节蛋白衰变加速因子(DAF,CD55)和膜辅因子蛋白(MCP,CD46)可控制C3转化酶,它们与膜攻击复合物(MAC)的抑制剂CD59一起,被发现存在于发育中的人胎盘中,从妊娠至少6周直至足月。免疫染色显示这些蛋白质在胎儿来源的滋养层上皮细胞上的分布存在差异,尤其是在早期胎盘中,其中含有具有不同增殖潜能和分化状态的滋养层细胞群。所有这三种蛋白质都表达于覆盖绒毛膜绒毛并与母体血液直接接触的终末分化合体滋养层上皮细胞上。CD59也表达于其下的绒毛细胞滋养层细胞及其绒毛外衍生物上。这两种细胞群显示出C3转化酶调节因子的差异表达。绒毛细胞滋养层细胞表达MCP,但基本不表达DAF。该细胞群增殖以产生绒毛外细胞滋养层细胞柱与DAF表达增加和MCP表达减少相关。在整个胎盘发育过程中,通过对分离的滋养层细胞膜进行固相结合测定评估,DAF的表达似乎低于MCP和CD59。早期胎盘也被发现同时含有DAF +和DAF - 的绒毛膜绒毛。相反,CD59的表达相对较高,并且在纯化的滋养层细胞中发现CD59的转录本比DAF的转录本丰富得多。补体调节蛋白似乎在整个妊娠期发挥重要作用,保护胎儿来源的人类胚胎免受母体补体的攻击。这些蛋白质在滋养层上的差异表达模式可能反映了胎盘内不同位置对特定功能活动的需求差异。